Transmission of extensively drug-resistant tuberculosis in South Africa

New England Journal of Medicine

Volumn 376, Issue 3, 2017, Pages 243-253

  Shah, N Sarita ^a,b,c   Auld, Sara C ^a   Brust, James C M ^c   Mathema, Barun ^d   Ismail, Nazir ^f   Moodley, Pravi ^g   Mlisana, Koleka ^g   Allana, Salim ^a   Campbell, Angela ^a   Mthiyane, Thuli ^g   Morris, Natashia ^h   Mpangase, Primrose ^g   Van Der Meulen, Hermina ^f   Omar, Shaheed V ^f   Brown, Tyler S ^d   Narechania, Apurva ^e   Shaskina, Elena ⁱ   Kapwata, Thandi ^h   Kreiswirth, Barry ⁱ   Gandhi, Neel R ^a,c  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Columbia University Mailman School of Public Health ^*  (United States)

^e DIVISION OF INVERTEBRATE ZOOLOGY   (United States)

^f NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^g UNIVERSITY OF KWAZULU NATAL   (South Africa)

^h SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

ⁱ PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; ISONIAZID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CD4 LYMPHOCYTE COUNT; CHILD; CLUSTER ANALYSIS; COMMUNITY; CONTACT EXAMINATION; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE INSERTION SEQUENCE; GENE SEQUENCE; GENOTYPE; GLOBAL POSITIONING SYSTEM; HOSPITAL; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOCIAL NETWORK; SOUTH AFRICA; TREATMENT OUTCOME; WHOLE GENOME SEQUENCING; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMPLICATION; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENETICS; MICROBIOLOGY; MIDDLE AGED; PHYLOGENY; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL SUPPORT; TRANSMISSION; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SOCIAL SUPPORT; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 85010962133     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1604544     Document Type: Article

References (44)

1. Global tuberculosis report. Geneva: World Health Organization, 2015.
2. Pietersen E, Ignatius E, Streicher EM, et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. Lancet 2014; 383: 1230-9.
3. Liu CH, Li L, Chen Z, et al. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience. PLoS One 2011; 6(4): e19399.
4. Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP. Extensively drug-resistant tuberculosis in the United States, 1993-2007. JAMA 2008; 300: 2153-60.
5. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and secondline injectable drugs: impact on multidrug- resistant TB outcomes. Eur Respir J 2013; 42: 156-68.
6. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-80.
7. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007; 196: Suppl 1: S86-107.
8. Moro ML, Gori A, Errante I, et al. An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. AIDS 1998; 12: 1095-102.
9. Ritacco V, Di Lonardo M, Reniero A, et al. Nosocomial spread of human immunodeficiency virus-related multidrugresistant tuberculosis in Buenos Aires. J Infect Dis 1997; 176: 637-42.
10. Gelmanova IY, Keshavjee S, Golub- chikova VT, et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 2007; 85: 703-11.
11. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrugresistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992; 117: 191-6.
12. Annual tuberculosis report for South Africa, 2012: research, information, monitoring, evaluation and surveillance. Pretoria: National TB Control and Management Cluster, Department of Health, Republic of South Africa, 2016.
13. Shisana O, Rehle T, Simbayi L, et al. South African national HIV prevalence, incidence and behavior survey. Cape Town, South Africa: HSRC Press, 2014.
14. Ndjecka N. Multi-drug resistant tuberculosis: strategic overview on MDR-TB care in South Africa. Pretoria: Department of Health, Republic of South Africa, 2014.
15. Cook VJ, Sun SJ, Tapia J, et al. Transmission network analysis in tuberculosis contact investigations. J Infect Dis 2007; 196: 1517-27.
16. Clinical policies and protocols. 4th ed. New York: Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 2008.
17. Gandhi NR, Weissman D, Moodley P, et al. Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa. J Infect Dis 2013; 207: 9-17.
18. Plus R: a suite of publicly available software programs for collecting and processing cancer registry data. Atlanta: National Center for Chronic Disease Prevention and Health Promotion, 2015.
19. Borgatti SP, Everett MG, Freeman LC. Ucinet 6 for Windows: software for social network analysis. Harvard, MA: Analytic Technologies, 2002.
20. Shah NS, Wright A, Bai G-H, et al. Worldwide emergence of extensively drugresistant tuberculosis. Emerg Infect Dis 2007; 13: 380-7.
21. World TB Day - March 24, 2016. MMWR Morb Mortal Wkly Rep 2016; 65: 273.
22. Farley JE, Tudor C, Mphahlele M, et al. A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa. Int J Tuberc Lung Dis 2012; 16: 82-9.
23. Tudor C, Van der Walt M, Hill MN, Farley JE. Occupational health policies and practices related to tuberculosis in health care workers in KwaZulu-Natal, South Africa. Public Health Action 2013; 3: 141-5.
24. Walker TM, Lalor MK, Broda A, et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study. Lancet Respir Med 2014; 2: 285-92.
25. Guerra-Assunção JA, Crampin AC, Houben RM, et al. Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area. Elife 2015; 4: 4.
26. Bryant JM, Schürch AC, van Deutekom H, et al. Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data. BMC Infect Dis 2013; 13: 110.
27. Glynn JR, Guerra-Assunção JA, Houben RM, et al. Whole genome sequencing shows a low proportion of tuberculosis disease is attributable to known close contacts in rural Malawi. PLoS One 2015; 10(7): e0132840.
28. Marais BJ, Mlambo CK, Rastogi N, et al. Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa. J Clin Microbiol 2013; 51: 1818-25.
29. Becerra MC, Appleton SC, Franke MF, et al. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet 2011; 377: 147-52.
30. Devaux I, Kremer K, Heersma H, Van Soolingen D. Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis 2009; 15: 1052-60.
31. Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012; 366: 2161-70.
32. Yang C, Shen X, Peng Y, et al. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis 2015; 61: 219-27.
33. Li X, Zhang Y, Shen X, et al. Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J Infect Dis 2007; 195: 864-9.
34. Said HM, Kock MM, Ismail NA, et al. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa. J Clin Microbiol 2012; 50: 2857-62.
35. Basu S, Andrews JR, Poolman EM, et al. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 2007; 370: 1500-7.
36. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333: 229-33.
37. Barrera E, Livchits V, Nardell E. F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy. Int J Tuberc Lung Dis 2015; 19: 381-4.
38. Loveday M, Wallengren K, Brust J, et al. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis 2015; 19: 163-71.
39. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrugresistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348: 119-28.
40. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014; 383: 424-35.
41. Shah NS, Yuen CM, Heo M, Tolman AW, Becerra MC. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis 2014; 58: 381-91.
42. Grandjean L, Gilman RH, Martin L, et al. Transmission of multidrug-resistant and drug-susceptible tuberculosis within households: a prospective cohort study. PLoS Med 2015; 12(6): e1001843.
43. Andrews JR, Gandhi NR, Moodley P, et al. Exogenous reinfection as a cause of multidrug-resistant and extensively drugresistant tuberculosis in rural South Africa. J Infect Dis 2008; 198: 1582-9.
44. Yuen CM, Amanullah F, Dharmadhikari A, et al. Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment. Lancet 2015; 386: 2334-43.